A study found a link between methamphetamine, cocaine, opiates, and cannabis use and developing atrial fibrillation (AFib). Bernd Wüstneck/picture alliance via Getty Images.
Cannabis and other drugs linked to increased AFib risk
- An observational study found associations between methamphetamine, cocaine, opiates, and cannabis use and atrial fibrillation (AFib).
- Compared to non-users, the researchers’ analysis shows that the substances were individually associated with an increased risk of developing AFib after adjusting for cardiovascular risk factors.
- Cannabis use was linked to a 35% increase in the chances of developing AFib.
- Methamphetamine was associated with the greatest risk at an increase of 86%.
According to the American Heart Association (AHA)Trusted Source, more than 2.7 million Americans live with atrial fibrillation (AFib), a condition that causes irregular heartbeat or arrhythmia.
AFib can lead to blood clots, stroke, heart failure, and other serious heart problems.
A new observational study investigated the long-term effects of drugs like methamphetamine, cocaine, opiates, and cannabis and found a link to increased risk for AFib.
“The adverse effects of these drugs are couched in the context of an immediately catastrophic event that either occurs, or it doesn’t, which makes sense as most of the medical literature on the subject is based largely on case reports,” study author Dr. Gregory M. Marcus, professor of medicine at the University of California San Francisco, told Medical News Today.
Dr. Marcus added that the study provides “unique evidence that use of these substances heightens the longer-term risk of developing a chronic disease that is known to adversely affect patients in a fashion that is often lifelong.”
The study was recently published in Oxford Academics’ European Heart Journal.
Dr. Rigved Tadwalkar, a board certified cardiologist at Providence Saint John’s Health Center in Santa Monica, CA, not involved in the study, told MNT that people may experience atrial fibrillation in different ways.
“Some people can be completely asymptomatic when they have fibrillation, others might just feel some minor palpitations, which is really just an irregular-heartbeat sensation,” Dr. Tadwalkar said.
“Others can actually have pretty extreme distress when they go into AFib, just because their heart rate can be so rapid that it can cause, not just the sensation of severe palpitations, but also shortness of breath, lightheadedness, and also chest pain.”
According to Dr. Tadwalkar, AFib may not always be detected during a checkup because symptoms do not always appear.
“You may go into your doctor’s office, have an EKG, and not have the atrial fibrillation found because basically that EKG is [just] a several-second strip of what’s happening,” he explained.
In addition, AFib may complicate other health conditions.
“Someone who comes in really sick with an infection such as pneumonia or urinary tract infection — but then also has atrial fibrillation precipitated by that, on top — it can really make their hospitalization a lot more complex,” Dr. Tadwalkar added.
“In the longer term, we’re most concerned about atrial fibrillation because there’s a risk of embolism and blood clots. While these blood clots can go anywhere, the one that we are most concerned about, because of its proximity to the heart and because it is frequent in terms of incidence, is the possibility of stroke.”
– Dr. Rigved Tadwalkar, board certified cardiologist
Dr. Tadwalkar said that some risk factors for AFib are out of our control, including aging and family history.
He noted that high blood pressure and lifestyle factors like alcohol and tobacco use could also increase a person’s risk for AFib.
“Theoretically, if someone is taking care of their health better, there should be a lower risk that they develop atrial fibrillation,” Dr. Tadwalkar said.
For the study, researchers began with data from 23,561,884 California residents who had visited an emergency department, outpatient surgery facility, or hospital from January 2005 through December 2015.
Of these people, 98,271 reported using methamphetamine, 48,701 used cocaine, 10,032 used opiates, and 132,834 used cannabis.
Over the study period, 42%, or 998,747 patients (4.2%) without previous AFib developed the condition.
After making adjustments for established cardiovascular risk factors, the researchers found:
- methamphetamine use increased AFib risk by 86%
- opiate use increased AFib risk by 74%
- cocaine use increased AFib risk by 61%
- cannabis use increased AFib risk by 35%
Methamphetamine was associated with the greatest increase of AFib risk. According to a news release, this was the first study to observe an association between cannabis use and an increased risk of developing AFib.
“A common limitation of studies investigating the use of various substances is a reliance on self-report, which may be especially unreliable in the context of illicit substances,” Dr. Marcus said. “The current study utilized healthcare coding [from the healthcare providers] instead.”
Dr. Tadwalkar added: “We sort of knew this, but we didn’t really have the granularity that this study provides.”
Dr. Marcus noted that while “many may consider cannabis to be healthy, these data suggest the contrary, providing evidence that may motivate some users to quit.”
Dr. Tadwalkar said the increased risk for AFib with cannabis use presents a significant public health issue.
“Any time there’s something out there that people enjoy, and then you sort of add the legal aspect, you sort of think that there’s a green light,” Dr. Tadwalkar said. “But those public health considerations have not been looked at in total, and I think that’s really the crux of the issue.”
Being an observational study, Dr. Marcus noted they were unable to determine specific types or amounts of substance use among subjects.
While not establishing a dose-response relationship between the drugs and AFib, Dr. Tadwalkar said the study may hint that its cohort included heavy users.
“The reason I say this is because the data collected from the study was from individuals who found care in more acute settings,” he said.
As for any difference in risk between smoking cannabis flower and consuming edibles, Dr. Marcus said the study was not able to distinguish different forms of cannabis consumption.
Dr. Tadwalkar explained the different drugs used in the study work in different ways but may have some similar effects.
“There are probably two common generalized mechanisms as to how they could be promoting atrial fibrillation,” Dr. Tadwalkar said.
“One is autonomic dysfunction [where] there is a rapid change, or a fairly rapid change, in how the sympathetic and parasympathetic nervous systems work. So, these changes in the nervous system are probably responsible to a large degree as to how fibrillation is initiated or promoted.”
“The second — which is a little bit more specific to the heart — is a phenomenon we call ‘electrical remodeling,’” [which consists of] changes in the activity of specific ion channels, and as a result, protein expression. For cannabis specifically, animal models have shown that a decrease in mitochondrialTrusted Source calcium content may make these myocytesTrusted Source, which are cardiac muscle cells, more prone to oxidative stress.”
Dr. Marcus hopes future research will answer the questions left unresolved by the current study.
“We would be interested to determine how much of these effects might be immediate versus requiring repeated and chronic use of these substances,” he said.
“Differentiating whether the mode of cannabis consumption matters is an important next step.”
“An observational study such as this one is ill-equipped to confidently infer causal relationships. We also hope to perform prospective interventional studies to more definitively address unknown and unmeasured confounding that may have been operative, despite our best attempts at statistical adjustment.”
– Dr. Gregory M. Marcus, study author